immunocorrecting effect of glucosamine-muramylpeptide in cases of bronchial asthma in children
Titova N.D., Novikova V.I.
1 Belarusian Medical Academy of Postgraduate Education
2 Vitebsk State Medical University
The application of glucosamine-muramylpeptide for allergic bronchial asthma treatment in children reduced the duration of asthma exacerbations caused by infection, increased sigA level, decreased total IgE, reduced the frequency of disimmunoglobulinaemia. decreased the IgE-level to fungal allergens, modified the cytokine profile from Th2 (IL-4, IL-5 j to Thl (IL-2. INFy).